APEX1 and cancer: Since several cancer-associated APE1 variants present mutations in the endonuclease domain, exhibiting only mild nuclease defects in vitro15–17, we hypothesize that APE1 non-canonical functions associated with its overexpression and/or an altered expression of its protein interacting partners should be related to cancer promotion.